The U.S. Food and Drug Administration (FDA) approved new drug Entyvio (vedolizumab) for the treatment of moderate to severe ulcerative colitis and Crohn’s disease. Vedolizumab is given injectable form. FDA has approved its use in patients with ulcerative colitis or Crohn’s disease in whom one or more o standard therapies like corticosteroids, immunomodulators or […]